Elizabeth L.R. Donley

Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics

Paul R. West, April M. Weir, Alan M. Smith et al. · Toxicology and Applied Pharmacology · 2010 · 185 citations

Pharmacy, Pharmacology, Toxicology +14

Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

Paul R. West, David G. Amaral, Preeti Bais et al. · PLoS ONE · 2014 · 153 citations · Full text

Life Sciences, Biochemistry, Autism Spectrum Disorders +15

Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder

Alan M. Smith, Joseph J. King, Paul R. West et al. · Biological Psychiatry · 2018 · 137 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics

Nicole Kleinstreuer, Alan M. Smith, Paul R. West et al. · Toxicology and Applied Pharmacology · 2011 · 104 citations

Pharmacy, Developmental Biology, Toxicology +16

Establishment and Assessment of a New Human Embryonic Stem Cell‐Based Biomarker Assay for Developmental Toxicity Screening

Jessica Palmer, Alan M. Smith, Laura A. Egnash et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2013 · 97 citations

Pharmacy, Developmental Biology, Toxicology +17